selectshandong@shandong.cn
中 日 한 EN DE FR
SELECTSHANDONG

Five Companies in Shandong Have Undertaken the National-Level Biomedical Materials Innovation Initiative

Source：Haibao News 11-05-2025 09:00:00

Recently, the Ministry of Industry and Information Technology and the National Medical Products Administration jointly announced the list of entities selected for the second batch of biomedical materials innovation initiatives for open competition. A total of 86 entities were selected to address challenges across 35 categories of materials.

Five companies from Shandong have been incorporated, including Weihai Weigao Blood Collection Consumables Co., Ltd., Qingdao Haier Biomedical Co., Ltd., Shandong Guyuchun Biotechnology Co., Ltd., Shandong Weigao Group Medical Polymer Company Limited, and Shandong Sinocera Functional Materials Co., Ltd. These companies are engaged in the areas of polyethylene terephthalate, non-phthalate plasticizers, polyester-polyethylene glycol copolymers, high-end polypropylene, and 3D printing zirconia ceramic inks, respectively.